[go: up one dir, main page]

NO20076675L - Aminopiperidinquinoliner og deres azaisosteriske analoger med antibakteriell aktivitet - Google Patents

Aminopiperidinquinoliner og deres azaisosteriske analoger med antibakteriell aktivitet

Info

Publication number
NO20076675L
NO20076675L NO20076675A NO20076675A NO20076675L NO 20076675 L NO20076675 L NO 20076675L NO 20076675 A NO20076675 A NO 20076675A NO 20076675 A NO20076675 A NO 20076675A NO 20076675 L NO20076675 L NO 20076675L
Authority
NO
Norway
Prior art keywords
antibacterial activity
medicaments
humans
warm
bacterial infections
Prior art date
Application number
NO20076675A
Other languages
English (en)
Norwegian (no)
Inventor
Folkert Reck
Marshall Morningstar
Hajnalka Hartl
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20076675L publication Critical patent/NO20076675L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/056Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20076675A 2005-05-24 2007-12-27 Aminopiperidinquinoliner og deres azaisosteriske analoger med antibakteriell aktivitet NO20076675L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68403005P 2005-05-24 2005-05-24
PCT/GB2006/001889 WO2006125974A1 (fr) 2005-05-24 2006-05-23 Quinoleines d’aminopiperidine et leurs analogues azaisosteriques presentant une activite antibacterienne

Publications (1)

Publication Number Publication Date
NO20076675L true NO20076675L (no) 2007-12-27

Family

ID=36685663

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20076675A NO20076675L (no) 2005-05-24 2007-12-27 Aminopiperidinquinoliner og deres azaisosteriske analoger med antibakteriell aktivitet

Country Status (14)

Country Link
US (1) US20090131444A1 (fr)
EP (1) EP1891078A1 (fr)
JP (1) JP2008542249A (fr)
KR (1) KR20080016577A (fr)
CN (1) CN101258157A (fr)
AU (1) AU2006250987A1 (fr)
BR (1) BRPI0609887A2 (fr)
CA (1) CA2608072A1 (fr)
IL (1) IL187134A0 (fr)
MX (1) MX2007014507A (fr)
NO (1) NO20076675L (fr)
RU (1) RU2007147413A (fr)
WO (1) WO2006125974A1 (fr)
ZA (1) ZA200709870B (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
CN101400674A (zh) * 2006-03-10 2009-04-01 埃科特莱茵药品有限公司 抗生素化合物
EP2001887B1 (fr) 2006-04-06 2010-09-15 Glaxo Group Limited Derives de pyrrolo-quinoxalinone en tant qu'agents antibacteriens
SG164384A1 (en) 2006-05-26 2010-09-29 Toyama Chemical Co Ltd Novel heterocyclic compound or salt thereof and intermediate thereof
TW200815425A (en) * 2006-06-08 2008-04-01 Speedel Experimenta Ag 2,5-disubstituted piperidines
CA2684659C (fr) * 2007-04-20 2015-11-24 Glaxo Group Limited Composes contenant de l'azote tricyclique utilises en tant qu'agents antibacteriens
JP5274553B2 (ja) * 2007-06-15 2013-08-28 アクテリオン ファーマシューティカルズ リミテッド 3−アミノ−6−(1−アミノ−エチル)−テトラヒドロピラン誘導体
MX2010008922A (es) 2008-02-20 2010-09-07 Actelion Pharmaceuticals Ltd Compuestos antibioticos azatriciclicos.
MY158520A (en) 2008-10-07 2016-10-14 Actelion Pharmaceuticals Ltd Tricyclic oxazolidinone antibiotic compounds
WO2010043714A1 (fr) 2008-10-17 2010-04-22 Glaxo Group Limited Composés azotés tricycliques utilisés comme agents antibactériens
KR101297450B1 (ko) * 2008-12-12 2013-08-20 액테리온 파마슈티칼 리미티드 5-아미노-2-(1-하이드록시-에틸)-테트라하이드로피란 유도체
WO2010126820A2 (fr) * 2009-04-30 2010-11-04 Merck Sharp & Dohme Corp. Préparation d'esters alkyliques d'acides oxo-azacycloalkylcarboxyliques n-protégés
PH12012501846A1 (en) * 2010-04-02 2013-02-04 Firmenich Incorporated Sweet flavor modifier
CA2780403C (fr) * 2011-06-17 2020-04-21 Forest Laboratories Holdings Ltd. Procedes de preparation de composes heterocycliques, y compris le trans-7-oxo-6-(sulfoxy)-1,6-diazabicyclo¬3,2,1|octane-2-carboxamide et ses sels
RU2617700C2 (ru) 2011-08-12 2017-04-26 Синомикс, Инк. Производные 4-аминохинолин-3-карбоновой кислоты и содержащие их композиции для усиления сладкого вкуса
WO2013149121A1 (fr) 2012-03-30 2013-10-03 Cubist Pharmaceuticals, Inc. Inhibiteurs de la 1,3,4-oxadiazole et de la 1,3,4-thiadiazole bêta-lactamase
AR090844A1 (es) * 2012-04-27 2014-12-10 Actelion Pharmaceuticals Ltd Proceso para elaborar derivados de naftiridina
EP2970338A1 (fr) 2013-03-14 2016-01-20 Merck Sharp & Dohme Corp. Forme cristalline d'un inhibiteur de bêta-lactamase
WO2015051101A1 (fr) 2013-10-02 2015-04-09 Cubist Pharmaceuticals, Inc. Sel picoline inhibiteur de b-lactamase
CN103613530B (zh) * 2013-12-02 2015-08-19 江苏弘和药物研发有限公司 一种芴甲氧羰基-3-哌啶醇的合成方法
ES2762581T3 (es) 2013-12-27 2020-05-25 Api Corp Método para producir ácido 5-hidroxipiperidina-2-carboxílico
WO2016027249A1 (fr) 2014-08-22 2016-02-25 Glaxosmithkline Intellectual Property Development Limited Composés contenant de l'azote tricyclique pour le traitement de l'infection à neisseria gonorrhoeae
BR112017008738B1 (pt) 2014-11-07 2021-06-15 Firmenich Incorporated Ácidos 4-amino-5-(ciclohexilóxi)quinolina-3-carboxílicos substituídos como modificadores de sabores adoçantes
TW201722965A (zh) * 2015-08-16 2017-07-01 葛蘭素史密斯克藍智慧財產發展有限公司 用於抗菌應用之化合物
AU2017276627A1 (en) * 2016-06-08 2018-12-20 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. New antibacterial compounds
CN110036004A (zh) 2016-07-13 2019-07-19 希洛斯医药品股份有限公司 细胞周期蛋白依赖性激酶7(cdk7)的抑制剂
ES2984497T3 (es) 2017-06-30 2024-10-29 Elanco Animal Health Gmbh Nuevos derivados de azaquinolina
IL301709B2 (en) 2017-08-09 2025-07-01 Denali Therapeutics Inc Compounds, compositions and methods
EP3676297B1 (fr) * 2017-09-01 2023-05-17 Denali Therapeutics Inc. Composés, compositions et procédés
JP7158393B2 (ja) 2017-09-14 2022-10-21 第一三共株式会社 環状構造を有する化合物
MX2021005007A (es) 2018-11-01 2021-07-21 Syros Pharmaceuticals Inc Inhibidores de cinasa 7 dependiente de ciclina (cdk7).
EP3924341A4 (fr) 2019-02-13 2022-11-02 Denali Therapeutics Inc. Composés, compositions et procédés
BR112021015639A2 (pt) 2019-02-13 2021-10-05 Denali Therapeutics Inc. Compostos, composições e métodos

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9822450D0 (en) * 1998-10-14 1998-12-09 Smithkline Beecham Plc Medicaments
DE60125373T2 (de) * 2000-07-26 2007-10-18 Smithkline Beecham P.L.C., Brentford Aminopiperidin chinoline und ihre azaisosteren analoga mit antibakterieller wirkung
EP1719770A3 (fr) * 2000-09-21 2008-03-05 Smithkline Beecham Plc Dérivés de quinoline comme agents antibactériens
JP4887297B2 (ja) * 2004-09-24 2012-02-29 アクテリオン ファーマシューティカルズ リミテッド 新規二環式抗生物質

Also Published As

Publication number Publication date
JP2008542249A (ja) 2008-11-27
KR20080016577A (ko) 2008-02-21
AU2006250987A1 (en) 2006-11-30
US20090131444A1 (en) 2009-05-21
BRPI0609887A2 (pt) 2011-10-11
IL187134A0 (en) 2008-02-09
MX2007014507A (es) 2008-02-07
ZA200709870B (en) 2008-11-26
CN101258157A (zh) 2008-09-03
CA2608072A1 (fr) 2006-11-30
RU2007147413A (ru) 2009-06-27
EP1891078A1 (fr) 2008-02-27
WO2006125974A1 (fr) 2006-11-30

Similar Documents

Publication Publication Date Title
NO20076675L (no) Aminopiperidinquinoliner og deres azaisosteriske analoger med antibakteriell aktivitet
NO20080338L (no) Forbindelser for behandling av multilegemiddelresistente bakterielle infeksjoner
NO20071776L (no) Kinoksaliner som B RAF inhibitorer.
NO20092476L (no) Antibakterielle polycykliske ureaforbindelser
NO20073719L (no) Kjemiske forbindelser
NO20081729L (no) Nye diazaspiroalkaner og deres anvendelse for behandling av CCR8-medierte sykdommer
NO20082709L (no) Kjemiske forbindelser
NO20074703L (no) Antibakterielle piperidinderivater
NO20071246L (no) Kinazolinonderivater og deres anvendelse som B-RAF-inhibitorer.
NO20072784L (no) Pyridenkarboksamidderivater for anvendelse som anticancer midler
NO20070199L (no) Substituerte kinazoloner som anti-kreftmidler
NO20064041L (no) Substituerte pyrazolin sammensetninger, deres fremstilling og anvendelse som medikamenter
NO20082269L (no) Nye piperaziner som antimalariamidler
NO20084257L (no) Diketopiperazin og piperidin derivater som antivirale midler
NO20064584L (no) Tetrahydropyridoindolderivater
EP2494059A4 (fr) Utilisation de méthysulfonylméthane (msm) à des fins de modulation de l'activité microbienne
NO20084202L (no) 4-anilinoquinolin-3-carboksamider som CSF-1R kinase inhibitorer
NO20092691L (no) 4-hydroksy-2-okso-2,3-dihydro-1,3-benzotiazol-7yl-forbindelser for modulering av B2-adrenoreseptoraktivitet
NO20072939L (no) Makroloner - aminosubstituerte kinoloner
NO20091683L (no) Kjemiske forbindelser
NO20090321L (no) Anvendelse av substituerte 2-aminotyetraliner for produksjon av et medikament for forhindringen, lettingen og/eller behandlingen av diverse typer smerte
NO20071245L (no) Kinazolinonderivater og deres anvendelse som b-RAF-inhibitorer.
NO20070655L (no) 2,4,6-Trisubstituerte pyrimidiner som fosfotidylinositol-(PI)-3-kinaseinhibitorer og disses anvendelse ved behandling av kreft
NO20070656L (no) 2,4,6-Trisubstituerte pyrimidiner som fosfotidylinositol-(PI)-3-kinaseinhibitorer og disses anvendelse ved behandling av kreft
NO20070566L (no) Azin-karboksamider som antikreftmiddel

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application